Neutrophil and macrophage activation and anaphylatoxin formation in orthotopic liver transplantation without the use of veno‐venous bypass
暂无分享,去创建一个
[1] M. Pinsky,et al. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. , 1993, Journal of critical care.
[2] D. Huhn,et al. Role of Leukocytes in Hemostasis During Orthotopic Liver Transplantation , 1993, Seminars in thrombosis and hemostasis.
[3] O. Stenqvist,et al. Complement activation during liver transplantation. , 1993, Transplantation.
[4] H. Jaeschke,et al. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. , 1993, The American journal of physiology.
[5] W. van Oeveren,et al. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[6] M. Elliott,et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.
[7] D. Shale,et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. , 1993, The Journal of thoracic and cardiovascular surgery.
[8] H. Kurosawa,et al. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators. , 1992, The Journal of thoracic and cardiovascular surgery.
[9] O. Stenqvist,et al. Isolated hyperthermic liver perfusion with cytostatic‐containing perfusate activates the complement cascade , 1992, The British journal of surgery.
[10] J. van der Meer,et al. Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. , 1992, Scandinavian journal of infectious diseases.
[11] H. Redl,et al. Bacterial Translocation in a Baboon Model of Hypovolemic-Traumatic Shock , 1991 .
[12] W. Hsueh,et al. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. , 1990, Immunology.
[13] P. Brandtzaeg,et al. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. , 1990, Thrombosis research.
[14] P. Brandtzaeg,et al. Complement activation and endotoxin levels in systemic meningococcal disease. , 1989, The Journal of infectious diseases.
[15] H. Berggren,et al. Altered concentrations of terminal complement complexes, anaphylatoxins, and leukotrienes in the coronary sinus during cardiopulmonary bypass. , 1989, Journal of cardiothoracic anesthesia.
[16] H. Teufelsbauer,et al. Neopterin as a new marker to detect acute rejection after heart transplantation. , 1989, The Journal of heart transplantation.
[17] G. Gunzer,et al. An automated homogeneous enzyme immunoassay for human PMN elastase. , 1989, Progress in clinical and biological research.
[18] C. Hack,et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. , 1989, The American journal of medicine.
[19] G. Slotman. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. , 1988, Surgery.
[20] A. Bengtsson,et al. IgG binding to cytoskeletal intermediate filaments activates the complement cascade. , 1987, Experimental cell research.
[21] M. Pinsky,et al. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. , 1987, Transplantation proceedings.
[22] M. Larsson,et al. Anaphylatoxin release in association with methylmethacrylate fixation of hip prostheses. , 1987, The Journal of bone and joint surgery. American volume.
[23] L. Ketai,et al. C3a and adult respiratory distress syndrome after massive transfusion , 1986, Critical care medicine.
[24] M. Heideman,et al. Altered anaphylatoxin activity during induced hypoperfusion in acute and elective abdominal aortic surgery. , 1986, The Journal of trauma.
[25] J. Murray,et al. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. , 1984, The American review of respiratory disease.
[26] F. Port,et al. Complement activation and hypersensitivity reactions to dialysis membranes. , 1984, The New England journal of medicine.
[27] T. Hugli,et al. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. , 1984, Analytical biochemistry.
[28] T. Hugli. Structure and function of the anaphylatoxins. , 1984, Springer seminars in immunopathology.
[29] S Westaby,et al. Complement and the damaging effects of cardiopulmonary bypass. , 1983, Thorax.
[30] H. Rokos,et al. A Radioimmunoassay for Determination of D-Erythro- Neopterin , 1983 .